PRO1107 in Patients With Advanced Solid Tumors
Conditions: Endometrial Cancer; Ovarian Cancer; Triple Negative Breast Cancer; GastroEsophageal Cancer; Non-small Cell Lung Cancer; Urothelial Carcinoma Interventions: Drug: PRO1107 Sponsors: ProfoundBio US Co. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Endometrial Cancer | Gastroenterology | Lung Cancer | Non-Small Cell Lung Cancer | Ovarian Cancer | Ovaries | Research